Cachexia is a condition associated with loss of weight and muscle mass in response to a chronic disease. The condition is a symptom of chronic disease such as cancer, diabetes, heart failure, chronic obstructive pulmonary disease etc. Amongst these, cancer is the main cause leading to cachexia. According to a study, it has been estimated that approximately 5 million Americans suffer from this condition. There are different conditions where a person loses weight; but cachexia is a condition where a person loses weight despite eating well. Usually a person who does not eat will lose fat but a person in this condition loses fat as well as muscle mass. Furthermore, it has been found that imbalance of certain substances in the body is responsible for developing cachexia. This imbalance may be due to the rise in the cytokines level in the blood which causes weight loss as cytokines are inflammatory substances. This rise in cytokines can occur in response to chronic health conditions which trigger cachexia. It is important to diagnose cachexia in case of chronic diseases such as heart failure, cancer, diabetes, chronic obstructive pulmonary disease etc. on the basis of an estimated 9 million people affected by cachexia in industrialized regions. It is important to differentiate cachexia from sarcopenia. Sarcopenia and muscle wasting are associated with reduced exercise capacity affecting quality of life but does not involve weight loss as in cachexia. The first step in the treatment of cachexia involves resistance training to build muscle if the person is physically capable to do so since there are no medicines approved for the treatment of cachexia. However, certain off-label medications which have been used in treating cachexia involve those which reduce cytokine levels in the body, and medicines to increase appetite and sometimes growth hormones.
The cachexia treatment market is forecasted to grow in the future owing to the rise in cancer patients and unmet needs to overcome cancer symptoms and difficult conditions like cachexia. In response to the requirements, many pharma companies are now in the process of developing vaccines and new drugs to combat cancer and its related challenging conditions. There are numerous drugs in the pipeline for the treatment of cachexia and some of them include Anamorelin, Bimagrumab etc.
The cachexia treatment market is segmented according to drug type, diet, exercise, and distribution channel. On the basis of drug type, the market is segmented into medications that reduce cytokines in the body, stimulate appetite such as Dronabinol, mega sterol acetate and corticosteroids, or medicines that block hormones associated with cachexia. Diet changes are suggested; however, they can rarely reverse the effects of cachexia. Exercise helps in building muscle mass. If a person is physically capable, resistance training using weights or resistance bands are helpful in treating muscle loss in cachexia.
Geographically, the cachexia market is segmented into five regions namely North America, Latin America, Europe, Asia Pacific (excluding Japan), and the Middle East & Africa. Though there is high demand for cachexia treatment drugs and supplements in all the regions, the market is currently dominated by developed regions such as the United States and Europe. Countries in Asia Pacific and Rest of the World are witnessing tremendous growth in healthcare infrastructure which is expected to propel the growth of the cachexia market.
Key players in the global cachexia market include Aeterna Zentaris Inc, Aphios Corporation, Novartis AG, Helsinn Healthcare S.A., PsiOxus Therapeutics Ltd, and Obexia AG.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.